Dual Diagnosis: Open Access is an peer-reviewed, open-access scholarly journal focused on publishing articles in all aspects of academic journal and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.

Depression is one of the major risk factors for the development, progression and prognosis of coronary heart disease (CHD). Patients with depression and CHD have high mortality and morbidity. Conventional antidepressant therapies achieve limited success in CHD patients.Chronic or repeated social stress exposure often precipitates the onset of depression and cardiovascular disease (CVD). Despite a clear clinical association between CVD and depression, the pathophysiology underlying these comorbid conditions is unclear. Chronic exposure to social stress can lead to immune system dysregulation, mitochondrial dysfunction, and vagal withdrawal. Further, regular physical exercise is well-known to exert cardioprotective effects, and accumulating evidence demonstrates the antidepressant effect of exercise.

Depression severity may reflect a “hidden moderator” of outcomes between trials. Greater depression severity may be a risk factor for reduced treatment response. Greater depression severity was associated with attenuated PTSD treatment efficacy.

Journal accepts original manuscripts in the form of research articles, review articles, Clinical reviews, commentaries, case reports, perspectives and short communications encompassing all aspects of Dual Diagnosis for publication in open access platform.

How to Publish

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21-day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Permanent free access to your article upon publication ensures extensive global reach and readership.

A strict single blinded peer review process is being followed to assess each submission and to enrich the quality. All published articles are indexed in the leading indexing services.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

You can Submit manuscript directly online https://www.imedpub.com/submissions/dual-diagnosis-open-access.html or as an attachment to this E-mail: dualdiagnosis@emedsci.com

Articles will be paid high attention during the Publication any immediate submission is highly appreciable.

Regards,
Nancy Ella
Journal Editor
Dual Diagnosis: Open Access
WhatsApp: +1-947-333-4405